Elevance Health, Inc. ELV
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 167.70B | 167.37B | 167.15B | 166.83B | 162.42B |
| Total Other Revenue | 34.14B | 33.74B | 33.27B | 32.29B | 32.40B |
| Total Revenue | 201.83B | 201.11B | 200.42B | 199.13B | 194.82B |
| Cost of Revenue | 148.48B | 148.84B | 148.53B | 148.22B | 143.66B |
| Gross Profit | 53.35B | 52.27B | 51.89B | 50.90B | 51.16B |
| SG&A Expenses | 44.96B | 44.24B | 43.49B | 41.98B | 41.73B |
| Depreciation & Amortization | 492.00M | 548.00M | 585.00M | 628.00M | 644.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 193.93B | 193.63B | 192.60B | 190.83B | 186.03B |
| Operating Income | 7.90B | 7.49B | 7.82B | 8.30B | 8.79B |
| Income Before Tax | 6.25B | 5.86B | 6.22B | 6.71B | 7.10B |
| Income Tax Expenses | 1.15B | 915.00M | 980.00M | 1.05B | 1.57B |
| Earnings from Continuing Operations | 5.10K | 4.95K | 5.24K | 5.66K | 5.53K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 36.00M | 16.00M | 6.00M | 1.00M | 5.00M |
| Net Income | 5.14B | 4.96B | 5.24B | 5.66B | 5.53B |
| EBIT | 7.90B | 7.49B | 7.82B | 8.30B | 8.79B |
| EBITDA | 9.39B | 9.00B | 9.34B | 9.84B | 10.32B |
| EPS Basic | 23.54 | 22.56 | 23.56 | 25.17 | 24.52 |
| Normalized Basic EPS | 18.65 | 17.26 | 18.00 | 19.15 | 20.51 |
| EPS Diluted | 23.45 | 22.50 | 23.51 | 25.12 | 24.46 |
| Normalized Diluted EPS | 18.58 | 17.21 | 17.96 | 19.10 | 20.46 |
| Average Basic Shares Outstanding | 875.20M | 881.90M | 890.10M | 896.70M | 906.00M |
| Average Diluted Shares Outstanding | 877.70M | 883.80M | 891.70M | 898.50M | 907.80M |
| Dividend Per Share | 6.87 | 6.86 | 6.85 | 6.84 | 6.76 |
| Payout Ratio | 29.17% | 30.36% | 28.97% | 27.00% | 27.56% |